111 related articles for article (PubMed ID: 3861606)
1. In-vitro activity of Sch 34343 against anaerobic bacteria.
Wexler H; Carter WT; Finegold SM
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():173-6. PubMed ID: 3861606
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of anaerobic bacteria to Sch 34343 and other antibiotics.
Glupczynski Y; Gordts B; van der Linden MP; Labbé M; Yourassowsky E; Butzler JP
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():193-8. PubMed ID: 4030548
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of anaerobic bacteria to Sch 34343 and other beta-lactam antibiotics.
Jacobus NV; Tally FP; Gorbach SL
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():189-91. PubMed ID: 4030547
[TBL] [Abstract][Full Text] [Related]
4. Comparative in-vitro activity of Sch 34343 and other antimicrobial agents against anaerobic bacteria.
Nord CE; Olsson-Liljequist B
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():183-8. PubMed ID: 2863246
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of imipenem against anaerobic bacteria.
Wexler HM; Finegold SM
Rev Infect Dis; 1985; 7 Suppl 3():S417-25. PubMed ID: 3901206
[TBL] [Abstract][Full Text] [Related]
6. Comparative activity of SCH 34343 against anaerobic bacteria.
Sutter VL; Wexler H; Finegold SM
Diagn Microbiol Infect Dis; 1986 Apr; 4(4):341-4. PubMed ID: 3698546
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of meropenem (SM-7338), imipenem, and five other antibiotics against anaerobic clinical isolates.
Murray PR; Niles AC
Diagn Microbiol Infect Dis; 1990; 13(1):57-61. PubMed ID: 2331851
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of anaerobic bacteria to meropenem.
Nord CE; Lindmark A; Persson I
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():113-7. PubMed ID: 2553656
[TBL] [Abstract][Full Text] [Related]
9. Comparative anti-anaerobic activity of Men 10700, a penem antibiotic.
Hamilton-Miller JM; Shah S
Int J Antimicrob Agents; 1998 Nov; 10(4):321-4. PubMed ID: 9916909
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of Sch 34343 and cefbuperazone against anaerobic bacteria.
Shafran SD; Wong J; Chow AW
Antimicrob Agents Chemother; 1985 May; 27(5):749-52. PubMed ID: 4015069
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of anaerobic bacteria to imipenem.
Tally FP; Jacobus NV
J Antimicrob Chemother; 1983 Dec; 12 Suppl D():47-51. PubMed ID: 6583197
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of cefotetan and Sch 34343 to beta-lactamases produced by strains of Bacteroides that hydrolyse cefoxitin or imipenem.
Andrew JH; Greenwood D
J Antimicrob Chemother; 1987 May; 19(5):591-5. PubMed ID: 3497146
[TBL] [Abstract][Full Text] [Related]
13. Comparative in-vitro activity of Sch 34343 for a wide spectrum of clinically significant anaerobic bacteria.
Wells CL; Wilkins TD
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():177-82. PubMed ID: 4030546
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of cefoperazone plus sulbactam compared with that of other antimicrobial agents against anaerobic bacteria.
Wexler HM; Finegold SM
Antimicrob Agents Chemother; 1988 Mar; 32(3):403-6. PubMed ID: 3364960
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of doripenem and comparator agents against 364 anaerobic clinical isolates.
Wexler HM; Engel AE; Glass D; Li C
Antimicrob Agents Chemother; 2005 Oct; 49(10):4413-7. PubMed ID: 16189137
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of L-627 against anaerobic bacteria.
Nord CE; Lindmark A; Persson I
Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):757-60. PubMed ID: 1425740
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of HMR 3647 against anaerobic bacteria.
Edlund C; Sillerström E; Wahlund E; Nord CE
J Chemother; 1998 Aug; 10(4):280-4. PubMed ID: 9720465
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of the Bacteroides fragilis group in community hospitals.
File TM; Thomson RB; Tan JS; Salstrom SJ; Jacobs GA; Johnson L; Tan L
Diagn Microbiol Infect Dis; 1986 Nov; 5(4):317-22. PubMed ID: 3465493
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.
Klietmann W; Focht J; Nösner K
Chemioterapia; 1987 Aug; 6(4):243-50. PubMed ID: 3477332
[TBL] [Abstract][Full Text] [Related]
20. [In vitro activities of sulopenem, a new parenteral penem, against anaerobes].
Watanabe K; Kato N; Tanaka-Bandoh K; Tanaka Y; Kato H; Ueno K
Jpn J Antibiot; 1996 Apr; 49(4):367-76. PubMed ID: 8786627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
